HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi Xia Selected Research

Inflammation (Inflammations)

3/2023Low Zinc Alleviates the Progression of Thoracic Aortic Dissection by Inhibiting Inflammation.
11/2022Nattokinase enhances the preventive effects of Escherichia coli Nissle 1917 on dextran sulfate sodium-induced colitis in mice.
11/2021Prognostic nutritional index, a novel biomarker which predicts worse prognosis in diffuse large B cell lymphoma.
5/2016Anticoagulant sodium alginate sulfates and their mussel-inspired heparin-mimetic coatings.
5/2012Astragaloside IV prevents MPP⁺-induced SH-SY5Y cell death via the inhibition of Bax-mediated pathways and ROS production.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi Xia Research Topics

Disease

66Neoplasms (Cancer)
04/2024 - 11/2004
28Lymphoma (Lymphomas)
03/2024 - 04/2006
27Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2024 - 04/2007
17B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2023 - 04/2007
10Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023 - 11/2004
9Neoplasm Metastasis (Metastasis)
04/2024 - 12/2006
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 02/2009
7Disease Progression
03/2024 - 12/2006
7Infections
01/2024 - 01/2005
7Hodgkin Disease (Hodgkin's Disease)
01/2022 - 03/2013
6Esophageal Squamous Cell Carcinoma
01/2021 - 01/2017
5Hepatocellular Carcinoma (Hepatoma)
04/2024 - 01/2017
5Breast Neoplasms (Breast Cancer)
01/2024 - 01/2014
5Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2023 - 10/2006
5Inflammation (Inflammations)
03/2023 - 05/2012
5Sepsis (Septicemia)
01/2023 - 01/2007
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2023 - 04/2007
5Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
01/2022 - 04/2007
4Vomiting
10/2019 - 08/2007
4B-Cell Lymphoma (Lymphoma, B Cell)
01/2019 - 08/2011
4Burkitt Lymphoma (Burkitt's Lymphoma)
01/2016 - 04/2007
4Parkinson Disease (Parkinson's Disease)
02/2014 - 10/2011
3Hypoxia (Hypoxemia)
04/2024 - 08/2020
3Emphysema
11/2023 - 11/2017
3Necrosis
11/2023 - 09/2018
3Nasopharyngeal Carcinoma
11/2023 - 01/2017
3Hypertension (High Blood Pressure)
11/2023 - 09/2013
3Waldenstrom Macroglobulinemia (Macroglobulinemia)
03/2023 - 05/2016
3Neutropenia
01/2023 - 06/2018
3Thrombocytopenia (Thrombopenia)
01/2023 - 06/2018
3Adenocarcinoma
10/2021 - 01/2019
3Dermatitis
10/2019 - 03/2017
3Fatigue
10/2019 - 03/2017
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2019 - 05/2009
3Carcinoma (Carcinomatosis)
06/2018 - 03/2017
3Neurodegenerative Diseases (Neurodegenerative Disease)
02/2014 - 05/2012
2Chronic Obstructive Pulmonary Disease (COPD)
02/2024 - 01/2021
2Colitis
12/2023 - 11/2022
2Aortic Dissection
11/2023 - 03/2023
2Rupture
11/2023 - 03/2023
2Glioma (Gliomas)
08/2023 - 10/2013
2Circulating Neoplastic Cells
02/2023 - 01/2023
2Stomach Neoplasms (Stomach Cancer)
02/2023 - 10/2010
2Lymphoid Leukemia
01/2023 - 04/2007

Drug/Important Bio-Agent (IBA)

14Proteins (Proteins, Gene)FDA Link
08/2023 - 06/2012
14Rituximab (Mabthera)FDA Link
01/2023 - 02/2009
12Biomarkers (Surrogate Marker)IBA
02/2024 - 10/2008
8GemcitabineFDA Link
03/2024 - 04/2010
8DNA (Deoxyribonucleic Acid)IBA
01/2023 - 05/2012
6Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2023 - 05/2009
6NUPR1 inhibitor ZZW-115IBA
01/2022 - 01/2019
6Cisplatin (Platino)FDA LinkGeneric
04/2020 - 01/2017
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2024 - 05/2009
5Indicators and Reagents (Reagents)IBA
04/2023 - 06/2009
5Intrinsically Disordered ProteinsIBA
10/2021 - 01/2019
5Paclitaxel (Taxol)FDA LinkGeneric
10/2019 - 01/2017
4Prednisone (Sone)FDA LinkGeneric
01/2024 - 06/2012
4Fluorouracil (Carac)FDA LinkGeneric
01/2024 - 03/2017
4Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
03/2023 - 01/2018
4N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA
01/2023 - 01/2020
4Fibrinogen (Factor I)FDA Link
01/2023 - 04/2019
4Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2018
4Vitamin DFDA LinkGeneric
02/2021 - 04/2020
4MicroRNAs (MicroRNA)IBA
04/2020 - 10/2010
4AlbuminsIBA
04/2019 - 01/2016
4Vincristine (Oncovin)FDA LinkGeneric
07/2016 - 05/2009
4NucleosidesIBA
01/2015 - 12/2010
3EnzymesIBA
04/2024 - 02/2023
3AntioxidantsIBA
03/2024 - 10/2021
3Oxaliplatin (Eloxatin)FDA LinkGeneric
03/2024 - 06/2018
3LigandsIBA
10/2023 - 01/2015
3Messenger RNA (mRNA)IBA
08/2023 - 10/2018
3ibrutinibIBA
01/2023 - 10/2019
3CytokinesIBA
11/2022 - 02/2016
3Methotrexate (Mexate)FDA LinkGeneric
03/2022 - 05/2009
3ParaproteinsIBA
01/2022 - 05/2016
3Inosine Diphosphate (IDP)IBA
10/2021 - 01/2019
3Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2020 - 01/2012
3L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
10/2019 - 01/2013
3AntibodiesIBA
01/2016 - 04/2007
3TriazolesIBA
01/2015 - 10/2009
3Nerve Growth Factors (Neurotrophins)IBA
02/2014 - 10/2011
3Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2014 - 10/2011
2Glucose (Dextrose)FDA LinkGeneric
04/2024 - 09/2013
2Small Interfering RNA (siRNA)IBA
04/2024 - 10/2023
2Therapeutic UsesIBA
03/2024 - 01/2016
2HydrogelsIBA
01/2024 - 01/2023
2Oxygen (Dioxygen)IBA
01/2024 - 08/2020
2anlotinibIBA
11/2023 - 08/2022
2CholesterolIBA
04/2023 - 01/2021
2oxidized low density lipoproteinIBA
04/2023 - 11/2021
2LDL CholesterolIBA
04/2023 - 11/2021
2LipidsIBA
04/2023 - 08/2019

Therapy/Procedure

35Therapeutics
01/2024 - 04/2006
19Drug Therapy (Chemotherapy)
01/2024 - 10/2005
12Radiotherapy
01/2024 - 12/2006
6Chemoradiotherapy
01/2021 - 03/2017
3Consolidation Chemotherapy
06/2018 - 07/2009
3VAP-cyclo protocol
10/2015 - 12/2007
2Immunotherapy
02/2024 - 10/2023